Risk Factors for the Development of Diabetes Mellitus After Distal Pancreatectomy
1 other identifier
observational
485
1 country
1
Brief Summary
Glucose homeostasis changes after distal pancreatectomy are not well understood. This study aim to identify the incidence of and risk factors for, a change in glucose homeostasis in patients who underwent distal pancreatic resection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2004
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 13, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 13, 2016
CompletedFirst Submitted
Initial submission to the registry
September 17, 2016
CompletedFirst Posted
Study publicly available on registry
January 24, 2017
CompletedSeptember 2, 2020
September 1, 2016
12.1 years
September 17, 2016
September 1, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants with new-onset diabetes mellitus as defined by American Diabetes Association
The criteria for the diagnosis of diabetes developed by American Diabetes Association (1) FPG (fasting plasma glucose) ≥ 126 mg/dL (7.0 mmol/L). Fasting is defined as no caloric intake for at least 8 h.\* OR (2) 2-h PG (plasma glucose) ≥ 200 mg/dL (11.1mmol/L) during an OGTT (oral glucose tolerance test). The test should be performed as described by the WHO, using a glucose load containing the equivalent of 75 g anhydrous glucose dissolved in water.\* OR (3) A1C ≥ 6.5% (48 mmol/mol). The test should be performed in a laboratory using a method that is NGSP certified and standardized to the DCCT assay.\* (lower-upper limit: 4.5%-6.3% in PUMCH) OR (4) In a patient with classic symptoms of hyperglycemia or hyperglycemic crisis, a random plasma glucose ≥ 200 mg/dL (11.1 mmol/L). \*In the absence of unequivocal hyperglycemia, results should be confirmed by repeat testing.
Through study completion, an average of 3 year
Secondary Outcomes (2)
Number of participants with new-onset prediabetes as defined by American Diabetes Association
Through study completion, an average of 3 year
Number of participants with new-onset exocrine insufficiency
Through study completion, an average of 3 year
Study Arms (1)
Distal Pancreatectomy
Patients undergoing distal pancreatectomy
Interventions
Distal pancreatectomy with or without splenectomy using minimal invasive or open approach
Eligibility Criteria
Patients undergoing distal pancreatectomy at our single tertiary referral hospital
You may qualify if:
- Patients undergoing distal pancreatectomy
You may not qualify if:
- Patients undergoing pancreaticoduodenectomy, middle pancreatectomy and enucleation
- Patients with preoperative DM
- Patients with functioning insulinoma and multiple endocrine neoplasia type 1
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Beijing, 100730, China
Related Publications (5)
Kwon JH, Kim SC, Shim IK, Song KB, Lee JH, Hwang DW, Park KM, Lee YJ. Factors Affecting the Development of Diabetes Mellitus After Pancreatic Resection. Pancreas. 2015 Nov;44(8):1296-303. doi: 10.1097/MPA.0000000000000404.
PMID: 26390413BACKGROUNDShirakawa S, Matsumoto I, Toyama H, Shinzeki M, Ajiki T, Fukumoto T, Ku Y. Pancreatic volumetric assessment as a predictor of new-onset diabetes following distal pancreatectomy. J Gastrointest Surg. 2012 Dec;16(12):2212-9. doi: 10.1007/s11605-012-2039-7. Epub 2012 Sep 28.
PMID: 23054900BACKGROUNDKing J, Kazanjian K, Matsumoto J, Reber HA, Yeh MW, Hines OJ, Eibl G. Distal pancreatectomy: incidence of postoperative diabetes. J Gastrointest Surg. 2008 Sep;12(9):1548-53. doi: 10.1007/s11605-008-0560-5. Epub 2008 Jun 10.
PMID: 18543045BACKGROUNDYou DD, Choi SH, Choi DW, Heo JS, Ho CY, Kim WS. Long-term effects of pancreaticoduodenectomy on glucose metabolism. ANZ J Surg. 2012 Jun;82(6):447-51. doi: 10.1111/j.1445-2197.2012.06080.x. Epub 2012 May 9.
PMID: 22571457BACKGROUNDDai M, Xing C, Shi N, Wang S, Wu G, Liao Q, Zhang T, Chen G, Wu W, Guo J, Liu Z. Risk factors for new-onset diabetes mellitus after distal pancreatectomy. BMJ Open Diabetes Res Care. 2020 Oct;8(2):e001778. doi: 10.1136/bmjdrc-2020-001778.
PMID: 33122295DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Menghua Dai, M.D.
Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 17, 2016
First Posted
January 24, 2017
Study Start
January 1, 2004
Primary Completion
February 13, 2016
Study Completion
February 13, 2016
Last Updated
September 2, 2020
Record last verified: 2016-09